Global Industrial Trend and Market Demand Study on Obesity Surgery Devices: Asia-Pacific to Witness Highest Growth by 2020
"Global
Market Study on Obesity Surgery Devices: Asia-Pacific to Witness
Highest Growth by 2020"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Obesity
is a chronic metabolic and genetic disease involving accumulation of
excessive or abnormal fat in the body. Obesity surgeries decrease the
size of the stomach, in order to limit the amount of food it can
hold. This limits the quantity of food patients can ingest, leading
to drastic weight loss. It has a beneficial effect on many medical
conditions such as acid reflux, low back pain, diabetes, sleep apnea,
hypertension, acid reflux, polycystic ovary syndrome (PCOS) and
urinary stress incontinence. Increasing prevalence of obesity among
children and adults is posing a threat in both developed and
developing nations. Obesity has a major impact on population
longevity and health-related expenses. Obesity surgeries result in
40% to 80% loss of excess weight after two to three years, depending
on the obesity surgery procedure.
Get
Sample
Report
With TOC @
http://www.researchmoz.us/enquiry.php?type=S&repid=320969
North
America is facing serious public health issues due to rising obesity
in the country. The U.S. accounted for 13% of obese persons worldwide
in 2013. Obesity is a major public health challenge in Europe.
Approximately, 52% of the population in the European Union was obese
or overweight in 2010. Obesity has reached epidemic proportions in
many countries in Asia Pacific. South East Asia and Western Pacific
regions are facing an epidemic of obesity-associated diseases such as
cardiovascular disorders and diabetes. Some of the leading factors
leading to obesity in the region are sedentary lifestyle, lack of
awareness and cultural attitude.
Increasing obesity epidemic and change in lifestyle are driving growth for obesity surgery devices market. Changes in nature of work, leisure time activities and food habits are the most significant contributing factors to the drastic increase of obesity in the world. In addition, increased medical tourism promotes obesity surgeries, as price is considered to be an important factor when it comes to obesity surgery. However, the selective nature of the surgery, long-term and short-term complications undergoing surgeries and limited insurance coverage restricts growth for the obesity surgery devices market. Obesity surgery is also not recommended for anyone suffering from serious illnesses such as cancer, liver diseases, cardiac, pulmonary and renal insufficiency. In addition, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable.
This report provides in-depth analysis and estimation of the obesity surgery devices market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The obesity surgery devices market is categorized on the basis of procedure for obesity surgery, devices and geography. Based on procedure of obesity surgery, the obesity surgery devices market comprises adjustable gastric banding, sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Based on devices, the market comprises staples, intragastric balloons, gastric bands and gastric electrical stimulation.
In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the obesity surgery devices market are Johnson & Johnson, Medtronic, Inc., Apollo Endosurgery Inc, Aspire Bariatrics, Spatz FGIA Inc., MetaCure and IntraPace Inc. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.
Increasing obesity epidemic and change in lifestyle are driving growth for obesity surgery devices market. Changes in nature of work, leisure time activities and food habits are the most significant contributing factors to the drastic increase of obesity in the world. In addition, increased medical tourism promotes obesity surgeries, as price is considered to be an important factor when it comes to obesity surgery. However, the selective nature of the surgery, long-term and short-term complications undergoing surgeries and limited insurance coverage restricts growth for the obesity surgery devices market. Obesity surgery is also not recommended for anyone suffering from serious illnesses such as cancer, liver diseases, cardiac, pulmonary and renal insufficiency. In addition, inadequate insurance coverage for the procedure and excessive cost of surgery often makes it unaffordable.
This report provides in-depth analysis and estimation of the obesity surgery devices market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics including market drivers, restraints, trends and strategic developments has been provided in the report. The obesity surgery devices market is categorized on the basis of procedure for obesity surgery, devices and geography. Based on procedure of obesity surgery, the obesity surgery devices market comprises adjustable gastric banding, sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Based on devices, the market comprises staples, intragastric balloons, gastric bands and gastric electrical stimulation.
In the geographical analysis, the report identifies and analyses market size and forecast of North America, Europe, Asia and Rest of the World (Row). Some of the major players in the obesity surgery devices market are Johnson & Johnson, Medtronic, Inc., Apollo Endosurgery Inc, Aspire Bariatrics, Spatz FGIA Inc., MetaCure and IntraPace Inc. These key market players have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability and financial overview.
Table
of Content
Chapter
1 Preface 9
1.1 Report Description 9
1.2 Research Methodology 10
1.3 Assumptions 10
Chapter 2 Market Synopsis 11
Chapter 3 Porter Five Forces Analysis 13
3.1 Bargaining power of suppliers 13
3.2 Bargaining power of buyers 14
3.3 Threat of new entrants 14
3.4 Threat of substitutes 14
3.5 Intensity of rivalry 14
Chapter 4 Industry Overview 15
4.1 Market Definition 15
4.2 Market Drivers 17
4.2.1 Global obesity endemic 17
4.2.2 Increasing sedentary lifestyle and junk food habits lead to obesity 18
4.2.3 Increasing prevalence of childhood obesity 19
4.2.4 Increasing medical tourism promotes medical surgery 20
4.3 Impact Analysis of Market Drivers 21
4.4 Market Restraints 22
4.4.1 Selective nature of obesity surgery 22
4.4.2 Long-term and short-term complication restrict patient from undergoing surgery 22
4.4.3 Limited insurance coverage for obesity surgery 23
4.5 Impact Analysis of Market Restraints 23
4.6 Market Trends 24
4.6.1 Demand for less invasive procedures for obesity surgery 24
4.6.2 Increasing demand for gastric electrical stimulation 24
Chapter 5 Global Market Size and Forecast 25
Chapter 6 Market Size and Forecast by Procedure 31
6.1 Sleeve Gastrectomy 31
6.2 Adjustable Gastric Banding 33
6.3 Roux-en-Y Gastric Bypass 35
6.4 Biliopancreatic Diversion with Duodenal Switch 37
Chapter 7 Market Size and Forecast by Devices 40
7.1 Intragastric Balloons 40
7.2 Gastric electrical stimulators 42
7.3 Gastric bands 44
7.4 Staples 46
Chapter 8 Market Size and Forecast by Geography 49
8.1 North America 49
8.2 Europe 51
8.3 Asia Pacific 54
8.4 Rest of the World 56
Chapter 9 Competitive Scenario 57
9.1 Competitive Benchmarking 57
Chapter 10 Company Profiles 59
10.1 Johnson & Johnson 59
10.1.1 Company Overview 59
10.1.2 Products and Services 59
10.1.3 Financial Performance 59
10.1.4 Recent Developments 60
10.2 Medtronic Inc 61
10.2.1 Company Overview 61
10.2.2 Products and Services 61
1.1 Report Description 9
1.2 Research Methodology 10
1.3 Assumptions 10
Chapter 2 Market Synopsis 11
Chapter 3 Porter Five Forces Analysis 13
3.1 Bargaining power of suppliers 13
3.2 Bargaining power of buyers 14
3.3 Threat of new entrants 14
3.4 Threat of substitutes 14
3.5 Intensity of rivalry 14
Chapter 4 Industry Overview 15
4.1 Market Definition 15
4.2 Market Drivers 17
4.2.1 Global obesity endemic 17
4.2.2 Increasing sedentary lifestyle and junk food habits lead to obesity 18
4.2.3 Increasing prevalence of childhood obesity 19
4.2.4 Increasing medical tourism promotes medical surgery 20
4.3 Impact Analysis of Market Drivers 21
4.4 Market Restraints 22
4.4.1 Selective nature of obesity surgery 22
4.4.2 Long-term and short-term complication restrict patient from undergoing surgery 22
4.4.3 Limited insurance coverage for obesity surgery 23
4.5 Impact Analysis of Market Restraints 23
4.6 Market Trends 24
4.6.1 Demand for less invasive procedures for obesity surgery 24
4.6.2 Increasing demand for gastric electrical stimulation 24
Chapter 5 Global Market Size and Forecast 25
Chapter 6 Market Size and Forecast by Procedure 31
6.1 Sleeve Gastrectomy 31
6.2 Adjustable Gastric Banding 33
6.3 Roux-en-Y Gastric Bypass 35
6.4 Biliopancreatic Diversion with Duodenal Switch 37
Chapter 7 Market Size and Forecast by Devices 40
7.1 Intragastric Balloons 40
7.2 Gastric electrical stimulators 42
7.3 Gastric bands 44
7.4 Staples 46
Chapter 8 Market Size and Forecast by Geography 49
8.1 North America 49
8.2 Europe 51
8.3 Asia Pacific 54
8.4 Rest of the World 56
Chapter 9 Competitive Scenario 57
9.1 Competitive Benchmarking 57
Chapter 10 Company Profiles 59
10.1 Johnson & Johnson 59
10.1.1 Company Overview 59
10.1.2 Products and Services 59
10.1.3 Financial Performance 59
10.1.4 Recent Developments 60
10.2 Medtronic Inc 61
10.2.1 Company Overview 61
10.2.2 Products and Services 61
Comments
Post a Comment